Tel: +27 82 556 8331
Email: craig@psyence.com
Website: www.psyence.com
Facebook: www.facebook.com/Psyence-Group-101285772038923
Linkedin: www.linkedin.com/company/the-psyence-group/
Instagram: www.instagram.com/psyence_group/
YouTube: www.youtube.com/channel/UCYF7lX0jEsbSmAE6H-vGF0Q
Twitter: https://twitter.com/PsyenceGroup
Psyence Group is a life science biotechnology company listed on the Canadian Securities Exchange (CSE: PSYG), with a focus on natural psychedelics. The Psyence Biomed Division works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. Our name “Psyence” combines the words psychedelic and science to affirm our commitment to producing psychedelic medicines developed through evidence-based research.
Informed by nature and guided by science, we built and operate one of the world’s first federally licensed commercial psilocybin mushroom cultivation and production facilities in Southern Africa. Our team brings international experience in both business and science and includes experts in mycology, neurology, palliative care, and drug development. We work to develop advanced natural psilocybin products for clinical research and development. Our key divisions, Psyence Production, Psyence Therapeutics and Psyence Function, anchor an international collaboration, with operations in Canada, the United Kingdom, Southern Africa, and a presence in the United States and Australia
